Squamous Cell Carcinoma (SCC) is a form of skin cancer that develops in the squamous cells.

Squamous Cell Carcinoma is one of the most common forms of skin cancer, and while it predominantly occurs in non-Hispanic White populations, it presents with distinct features and outcomes in the Black community. The incidence rates of SCC tend to be lower in African Americans, Hispanics, and Asian/Pacific Islanders, but they may experience more aggressive forms of SCC and lower survival rates when diagnosed. Click on the links below to learn more about SCC, Clinical Trials, and the Takeda[TRIAL NAME] study. It’s important to be AWARE of the signs, SCREEN when appropriate, and DIAGNOSE the disease EARLY.

Squamous Cell Carcinoma (SCC)
is a common skin cancer that starts in the squamous cells.

Do you know how to spot the signs of Squamous Cell Carcinoma?

Let’s shine a light on early detection! 

  • Firm red nodules
  • Flat sores with a scaly crust
  • Rough or scaly patches on the skin
  • Patch that bleeds or develops an open sore
  • Skin blemishes that take on the appearance of warts
  • Skin sores that do not heal
  • Skin nodules with raised borders
  • Tenders or pain in the affected area
  • Changes in the size, shape, or color of a skin lesion

If you notice any of these symptoms or experience concerning changes in your skin, it’s essential to seek evaluation from a dermatologist promptly. Early detection and intervention can significantly improve the outcome in dealing with SCC.

Read our Latest Research on Squamous Cell Carcinoma

What is Chronic Kidney Disease (CKD)?

More than 1 in 7 adults in the U.S. may have chronic kidney disease (CKD)—and most people don’t know...

Managing Chronic Kidney Disease

About 20% of Black Americans have Chronic Kidney Disease. Once it is diagnosed, the condition is not reversible. However,...

What Are My Options as a Patient?

We strive to educate and help patients and their family members that are interested in clinical research understand the process and what it means to be a clinical research participant.

The Surveillance, Epidemiology, and End Results (SEER) Program provides information on cancer statistics in an effort to reduce the cancer burden among the U.S. population. SEER is supported by the Surveillance Research Program (SRP) in NCI’s Division of Cancer Control and Population Sciences (DCCPS).

Takeda is currently conducting a clinical trial for Squamous Cell Carcinoma. You can get more information and details on the ClinicalTrial.gov site by clicking below.

Stay Up-to-Date with Our Weekly "Black Health Matters" Newsletters Straight Into Your Inbox!

SIGN UP FOR THE BLACK HEALTH MATTERS WEEKLY NEWSLETTER

Stay Up-to-Date with Our Weekly "Black Health Matters" Newsletters Straight Into Your Inbox!

SIGN UP FOR THE BLACK HEALTH MATTERS WEEKLY NEWSLETTER
Â

Related Articles